Skip to main content

Table 6 Duodenal dosimetry and treatment factors for patients with Grade 3+ toxicity

From: Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity

Grade 3+

Toxicity

Treatment Factors

Duodenal Dosimetry

Fids

PTV

Prescribed Dose

Dur’n

D0.035 cc

D1.0 cc

D5.0 cc

D10.0 cc

V15 Gy

V20 Gy

ACUTE

 Grade 3 pain

4

39.84 cc

30.0 Gy 3 fractions

3 days

33.9 Gy*

25.4 Gy

15.8 Gy

12.8 Gy*

5.9 cc

2.5 cc

 Grade 3 fatigue

3

44.22 cc

30.0 Gy 3 fractions

3 days

34.9 Gy*

27.9 Gy

20.5 Gy*

16.2 Gy*

12.3 cc

5.4 cc

 Grade 3 obstructive jaundice

4

119.57 cc

21.0 Gy 3 fractions

3 days

23.8 Gy*

22.6 Gy

21.1 Gy*

19.6 Gy*

32.2 cc

8.6 cc

LATE

 Grade 4 duodenal stricture

1

20.34 cc

28.5 Gy 3 fractions

5 days

11.2 Gy

8.3 Gy

6.8 Gy

6.2 Gy

0.0 cc

0.0 cc

 Grade 4 GI bleed

1

83.49 cc

27.0 Gy 3 fractions

5 days

29.3 Gy*

28.3 Gy

26.2 Gy*

23.9 Gy*

39.1 cc

19.4 cc

 Grade 4 GI bleed

3

109.31 cc

22.0 Gy 3 fractions

3 days

24.2 Gy*

23.2 Gy

22.5 Gy*

21.8 Gy*

63.3 cc

24.3 cc

 Grade 4 duodenal stricture

3

104.25 cc

27.0 Gy 3 fractions

3 days

31.6 Gy*

29.1 Gy

26.0 Gy*

21.8 Gy*

24.2 cc

12.8 cc

  1. *Duodenal planning dosimetry exceeded institution preferred 3 fraction constraints. † single fiducial conferring anticipated increased risk of duodenal complications [47]